John R. Strawn, Jr.
Chairman of the Board
Mr. Strawn has served as a member of our Board of Directors since July 2011. Mr. Strawn brings to the Board of Directors over 25 years of legal experience, including extensive knowledge of our intellectual property portfolio. His practice focuses on complex commercial litigation. Mr. Strawn has successfully represented the company for over 10 years, including in a dispute over the ownership and licensing of multiple patents. After prevailing in a jury trial that was upheld on appeal in 2009, the matter was settled on favorable terms for the company. In 2010, Mr. Strawn became a founding partner of Strawn Pickens LLP in Houston, Texas. Prior to founding Strawn Pickens, Mr. Strawn was the Co-Managing Partner of Cruse Scott Henderson & Allen LLP, a law firm based in Houston, Texas, since 1992. Mr. Strawn received his Juris Doctor from the University of Texas Law School and his bachelor’s degree from Dartmouth College.
Anthony G. Bruzzese, M.D.
Dr. Bruzzese has served as Chairman of our Board of Directors since April 2004. He is a practicing radiologist in Warwick, Rhode Island, certified by both the American Board of Internal Medicine and the American Board of Radiology. Since 1997, Dr. Bruzzese has served as a principal at Toll Gate Radiology, Inc., providing patients with comprehensive diagnostic imaging services. Dr. Bruzzese also has served on the medical staffs at Roger Williams Medical Center since 2008 and Landmark Medical Center since 2011. He previously served on the medical staff at Kent County Memorial Hospital in Rhode Island from 1997 to 2005. Dr. Bruzzese has served as a Fellow, Councilor and Alternate Councilor to the American College of Radiology on behalf of the Rhode Island Radiology Society. Dr. Bruzzese received his Bachelor of Science and Doctor of Medicine from Brown University. Dr. Bruzzese brings to the Board of Directors over 20 years of experience in medical practice. The Board of Directors believes that Dr. Bruzzese’s knowledge of internal medicine and life sciences will assist us in our future growth and expansion plans.
Dr. Michael Borenstein, Ph.D.
Dr. Borenstein is a board-certified dermatologist who specializes in medical and surgical dermatology, as well as the latest techniques in laser treatments and cosmetic dermatology. Dr. Borenstein received his Bachelor of Arts degree from Columbia University and his medical degree from the University of Miami School of Medicine. Dr. Borenstein joined Gardens Dermatology after completing his internship in internal medicine and residency in dermatology and cutaneous surgery at the University of Miami School of Medicine. Dr. Borenstein completed his Ph.D. in molecular and cellular pharmacology at the University of Miami. Dr. Borenstein is an active member of the American Medical Association, American Academy of Dermatology, Florida Society of Dermatology, the Florida Society of Dermatologic Surgeons, and the Palm Beach County Dermatology Society.
Joseph V. DiTrolio, MD
Chief Medical Officer - U.S., Director
Joseph V. DiTrolio, MD, isa Diplomate of the American Board of Urology, a Clinical Professor of Surgery, Division of Urology at New Jersey Medical School, the Treasurer, Board of Governors for the Stone Center of New Jersey, and the immediate past Chairman of the Department of Urology for the St. Barnabas Medical Center Healthcare System.
Dr. DiTrolio has served as a medical consultant for Fortune 500 Healthcare companies including Novartis, Sanofi-Aventis, AstraZeneca, Allergan, et al. He is also the current Medical Director for OneMedPlace. He is the holder of several patents.
Dr. DiTrolio’s experience across patient care, clinical research, and new product development brings great value to IMMUDYNE as the Company prepares to rollout new dietary supplement product lines through physician networks and practices. Dr. DiTrolio is a graduate of the University of Richmond, University of Paris, Sorbonne. He received his Medical Degree from New Jersey Medical School.
Ryan Aldridge is the founder of Aranea Partners. Aranea is a boutique capital markets advisory firm that specializes in investing in and advising companies in the healthcare sector. Ryan is an advisor to high net worth investors and an investor and consultant to early stage biotechnology and healthcare companies. Prior to Aranea, Ryan was the Director of Investor Relations at a long short hedge fund. Ryan graduated Gettysburg College in 2006 and is a CFA Charterholder.
President, Chief Executive Officer, Director
Mark McLaughlin has an extensive business background and financial expertise. With 10 years as an investment advisor at Lehman Brothers and 3 years at Oppenheimer & Company, Mr. McLaughlin gained experience across raising capital and business development. Thereafter, Mr. McLaughlin teamed up to manage money with Chris Cadbury, as a 50% Partner in Cadbury Asset Management, utilizing the proprietary indicators of Mr. Cadbury.
Mr. Cadbury’s market indicators were ranked number one in the U.S. by Timer Digest for 2002 and 2011. Mr. McLaughlin continues to collaborate with Mr.Cadbury. Prior to becoming the CEO of ImmuDyne in 2011, Mr. McLaughlin played an integral role in successfully prosecuting several IP violations in ImmuDyne’s favor, as well as streamlining and improving the Company’s operating efficiencies to properly position the Company as It commercializes Its technologies. Mr. McLaughlin is a graduate of Holy Cross, Worcester, MA